Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZYME
#2064
Zymeworks Inc. - Common Stock
24.9
8
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.16%
Monthly Change
+8.51%
6 month change
+1.13%
Year Change
+40.81%
Previous Close
24.9
4
Open
24.6
9
Low
24.6
6
High
24.9
8
Volume
43
Markets
US Stock Market
Healthcare
Biotechnology
ZYME
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
64.04 M
70.57 M
69.58 M
73.75 M
73.02 M
Valuation ratios
Enterprise value
81.96 M
574.94 M
952.5 M
1.9 B
1.7 B
Price to earnings ratio
3.97
-6.03
-9.04
-24.38
-19.44
Price to sales ratio
1.19
9.4
14.56
18.74
25.13
Price to cash flow ratio
3.41
6.04
10.09
-60.16
-26.46
Price to book ratio
1
1.54
3.28
7.4
1.86
Enterprise value to EBITDA ratio
0.59
-4.5
-7.42
-22.41
-17.3
Profitability ratios
Return on assets %
0.19
-0.2
-0.26
-0.23
-0.09
Return on equity %
0.25
-0.26
-0.36
-0.3
-0.27
Return on invested capital %
427.95
-377.9
-201.55
-139.98
-75.97
Gross margin %
100
100
100
100
100
Operating margin %
31.64
-181.62
-179.69
-87.34
-1 956.73
EBITDA margin %
33.4
-168.25
-168.31
-80.05
-1 876.54
Net margin %
30.14
-156.13
-160.8
-76.56
-1 833.97
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
5.7
7.41
3.4
5.88
10.82
Inventory turnover
—
—
—
—
—
Asset turnover
0.64
0.12
0.15
0.31
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
2.21
-1.72
-1.45
-0.44
-1.01
EBIT per share
2
-2
-1.81
-1.23
-1.52
EBITDA per share
2.11
-1.86
-1.69
-1.12
-1.31
Total debt per share
—
—
—
—
—
Cash per share
7.54
5.44
0.87
0.55
3.27
Net current asset value per share
8.35
6
3.96
3.3
5.16
Tangible book value per share
7.55
6.75
4.46
3.56
2.19
Working capital per share
6.88
5.19
2.8
2.74
4.69
Book value per share
7.55
6.75
4.46
3.56
2.19
News
Here’s Why Zymeworks Inc. Paid $929M For Theravance Biopharma (NASDAQ:ZYME)
Zymeworks Inc. (ZYME) M&A Call - Slideshow (NASDAQ:ZYME) 2026-06-30
Theravance Stock Down 3% After Zymeworks Announces Buyout
Zymeworks Inc. (ZYME) M&A Call Transcript
Zymeworks Inc. (ZYME) Q1 2026 Earnings Call Transcript
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates
uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Beat Estimates
Zymeworks at The Citizens Life Sciences Conference: Strategic Growth and Innovation
Zymeworks at Leerink Conference: Strategic Evolution and Clinical Progress
Stifel raises Zymeworks stock price target on royalty deal value
Citizens reiterates Zymeworks stock rating on strong cash position